Literature DB >> 24099604

Prevalence of atrial fibrillation in China and its risk factors.

Ying Li1, Yang Feng Wu, Ke Ping Chen, Xian Li, Xing Zhang, Gao Qiang Xie, Fang Zheng Wang, Shu Zhang.   

Abstract

OBJECTIVE: To study the prevalence of atrial fibrillation (AF) and the relation with its risk factors in China.
METHODS: A total of 19 363 participants (8635 males and 10 728 females) aged ⋝35 years in geographically dispersed urban and rural regions of China were included in this cross-sectional survey. All participants received questionnaire, physical and blood examination. Echocardiography were performed for AF patients found in the survey.
RESULTS: Of the 19 363 participants, 199 were diagnosed with AF. The estimated age-standardized prevalence of AF was 0.78% in men and 0.76% in women. The prevalence of AF in participants aged <60 years was 0.41% in men and 0.43% in women, and was 1.83% in both men and women aged ⋝60 years. About 19.0% of males and 30.9% of females with AF were diagnosed with valve disease. Age- and sex-adjusted multivariable logistic regression analysis revealed that myocardial infarction, left ventricular hypertrophy (LVH), obesity, and alcohol consumption were associated with a increased risk of AF(P<0.05).
CONCLUSION: The age standardized prevalence of AF is 0.77% in the participants enrolled in the present study. The number of AF cases aged ⋝35 years is 5.26 million according to 2010 Chinese Census. Most risk factors for AF, identified mainly in Western countries, are also detected in China.
Copyright © 2013 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Chinese population; Epidemiology; Risk factors

Mesh:

Year:  2013        PMID: 24099604     DOI: 10.3967/0895-3988.2013.09.001

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  29 in total

Review 1.  Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation: a meta-analysis.

Authors:  Xiaofeng Cheng; Xiaoqing Li; Yun He; Xiaoyan Liu; Guoqiang Wang; Li Cheng; Jianbo Hu
Journal:  J Interv Card Electrophysiol       Date:  2014-12-04       Impact factor: 1.900

Review 2.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

Review 3.  Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Authors:  Laila Staerk; Jason A Sherer; Darae Ko; Emelia J Benjamin; Robert H Helm
Journal:  Circ Res       Date:  2017-04-28       Impact factor: 17.367

Review 4.  Current progress of computational modeling for guiding clinical atrial fibrillation ablation.

Authors:  Zhenghong Wu; Yunlong Liu; Lv Tong; Diandian Dong; Dongdong Deng; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

Review 5.  Potential use of NOACs in developing countries: pros and cons.

Authors:  Durga Bista; Leanne Chalmers; Luke Bereznicki; Gregory Peterson
Journal:  Eur J Clin Pharmacol       Date:  2014-05-11       Impact factor: 2.953

6.  Screening for arrhythmia with the new portable single-lead electrocardiographic device (SnapECG): an application study in community-based elderly population in Nanjing, China.

Authors:  Jieqiong Guan; Ailian Wang; Wenjing Song; Nathan Obore; Pan He; Siyu Fan; Hong Zhi; Lina Wang
Journal:  Aging Clin Exp Res       Date:  2020-03-06       Impact factor: 3.636

Review 7.  The Optimal Treatment For Atrial Fibrillation In Less Developed Countries.

Authors:  Xiaohan Fan; Shu Zhang
Journal:  J Atr Fibrillation       Date:  2014-10-31

Review 8.  Review of screening studies for atrial fibrillation in rural populations of 11 countries.

Authors:  Alex I Gavino; Craig S McLachlan
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

9.  Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation.

Authors:  Ting Song; Xiao Xin; Peirong Cui; Mingcan Zong; Xianhua Li
Journal:  Patient Prefer Adherence       Date:  2021-03-01       Impact factor: 2.711

10.  In-hospital acute kidney injury and atrial fibrillation: incidence, risk factors, and outcome.

Authors:  Guoqin Wang; Lijiao Yang; Nan Ye; Weijing Bian; Changsheng Ma; Dong Zhao; Jing Liu; Yongchen Hao; Na Yang; Hong Cheng
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.